期刊文献+

左主干及三支病变经皮冠状动脉介入与冠状动脉搭桥术后随访对比研究 被引量:6

Comparison of outcome in patients with three-vessel and/or left main disease undergoing percutaneous coronary intervention and coronary artery bypass graft surgery
下载PDF
导出
摘要 目的总结比较冠心病(左主干和三支病变)患者接受经皮冠状动脉介入(PCI)或冠状动脉旁路移植术(CABG或者OPCAB)后的治疗效果。方法回顾性连续分析我院2009年9月到2012年9月期间行PCI或者CABG的左主干及三支病变患者,比较分析在住院期间、出院后12个月出现的终末事件,包括死亡、心肌梗死、心绞痛复发和再次介入等。结果共有1292例患者被纳入,分成PCI组626例,CABG组666例。随访12个月,90%的PCI和97%的CABG患者纳入。随访期间,PCI组死亡40例,CABG组死亡36例;心肌梗死PCI组36例,CABG组4例;再发心绞痛PCI组168例,CABG组18例;再干预PCI组134例,CABG组6例。心脑血管事件发生率CABG患者较PCI患者低(P〈0.05)。结论对三支和(或)左主干病变,CABG在减少不良心脑血管事件上优于PCI;但还需要更长期的随访研究。 Objective To compare the outcome including death, myocardial infarction, stroke, recurrent angina and need for re-intervention in patients with muhivessel disease undergoing pereutaneous intervention(PCI) or coronary artery bypass graft surgery(CABG). Methods A retrospective and ongoing analysis of consecutive pa- tients with three-vessel disease and/or left main stem undergoing PCI or CABG between September 2009 and September 2012 was carried out. In-hospital outcome and outcome measures at 12 months, including death, my- ocardial infarction, cerebrovascular events, recurrent angina and re-intervention were recorded. Results A total of 1292 patients were identified: 626 PCI and 666 CABG. At 12 months, data were available for 90% of PCI and 97% of CABG patients. During the follow-up period, 40 patients died in PCI group, 36 cases in CABG group, 36 patients of myocardial infarction in PCI group, 4 cases in CABG group, 168 patients recurrent angina in PCI group, 18 cases in CABG group, 134 casesreintervented in PCI group, 6 cases in CABG group. Death, myocar- dial infarction or stroke were less frequent in CABG than in PCI patients(P=0.01 ). Conclusion CABG is associ- ated with improved major adverse cardiovascular and cerebrovascular events in patients with three-vessel and/or left main stem disease compared with PCI at 12 months.
出处 《中国心血管病研究》 CAS 2015年第12期1139-1142,共4页 Chinese Journal of Cardiovascular Research
基金 上海市浦东新区卫生局卫生科技资助项目(项目编号:PW2010D-2)
关键词 左主干病变 三支病变 冠状动脉旁路移植术 经皮冠状动脉介入 Left main stem disease Three-vessel disease Coronary artery bypass graft surgery(CABG) Percutaneous coronary intervention(PCI )
  • 相关文献

参考文献15

  • 1Costa F, Ariotti S, Valgimigli M, et al. Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization Fifty Years of Revascularization: Where Are We and Where Are WeHeading? J of Cardiovasc Trans Res, 2015,8 : 211-220.
  • 2Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with muhivessel coronary artery disease. Circulation, 2007,123 : 34-42.
  • 3Qi x, Xu M, Yang H, et al. Comparing mortality and myocar- dial infarction between coronary artery bypass grafting and druge- luting stenting in patients with diabetes mellitus and muhivessel coronary artery disease: a meta-analysis. Arch Med Sci, 2014,10:411-418.
  • 4Fanari Z, Weiss SA, Zhang W, et al. Short, Intermediate and long term outcomes of CABG vs. PCI with DES in Patients With Multivessel Coronary" Artery Disease. Meta-Analysis of Six Ran- domized Controlled Trials. Eur J Cardiovasc Med, 2014,3 : 382- 389.
  • 5田利平,马惠芳,杨晓明,薛书峰,王晓阳,金军,李明琰,王亚宏,潘广杰,张红君.药物洗脱支架或冠状动脉搭桥术对冠状动脉多支病变的疗效观察[J].中国心血管病研究,2009,7(5):330-333. 被引量:1
  • 6Hannan EL, Racz MJ, Walford G, et al. Long term outcomes of coronary artery bypass grafting versus stent implantation. N Engl J Med, 2005,352 : 2174-2183.
  • 7Taggart DP. Coronary artery bypass grafting is still the best treat- ment for multivessel and left main disease, but patients need to know. Ann Thorac Surg, 2006,82 : 1966-1975.
  • 8Keating GM. Cangrelor: A Review in Percutaneous Coronary In- tervention. Eurolntervention, 2015,11 : V 111-114.
  • 9Dubois C, Dens J, Sinnaeve P, et al. Results of percutaneous coronary intervention of the unprotected left main coronary artery in 143 patients and comparison of 30-day mortality to results ofcoronary artery bypass grafting. Am J Cardiol,2008,101 : 75-81.
  • 10Serruys PW, Morice MC, Kappetein P, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. New Engl J Med,2009,360: 961-972.

二级参考文献2

共引文献13

同被引文献36

  • 1吴清玉,许建屏,高长青,万峰,孟强,吴若彬,肖明弟,肖锋,王东进,李洪银,李雷.冠状动脉旁路移植术技术指南[J].中华外科杂志,2006,44(22):1517-1524. 被引量:52
  • 2Park S J, Kim Y H, Park D W. Randomized trial of stents versus bypass surgery for left main coronary artery disease[J]. New England Journal of Medicine, 2011, 364(18) :1718- 1727.
  • 3Costa F, Ariotti S, Valgimigli M, et al. Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading? [J]. Journal of Cardiovascular Translational Research, 2015, 8(4).
  • 4Serruys P W. Pereutaneous Coronary Interventionversus Coronary- Artery Bypass Grafting - NEJM [J].New England Journal of Medicine.
  • 5KeelingW B, Kilgo P D, Puskas J D, et al. Of{- pump coronary artery bypass grafting attenuates mor- bidity and mortality for patients with low and high body mass index[J]. Journal of Thoracic ~ Cardio- vascular Surgery, 2013, 146(6) : 1442 - 1448.
  • 6Deja M A, Grayburn P A, Sun B, et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. [J]. Circula-tion, 2012, 125(21):2639 - 2648.
  • 7Patel N C, Deodhar A P, Grayson A D, et al. Neu- rological outcomes in coronary surgery: independent effect of avoiding cardiopulmonary bypass[J]. Annals of Thoracic Surgery, 2002, 74(2) :400 - 406.
  • 8Biancari F, Vasques F, Mikkola R, et al. Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery[J].Annals of Thoracic Sur- gery, 2012, 93(6):1930-1935.
  • 9牛兆倬,池一凡,侯文明,孙勇,孙忠东,孙龙.急诊冠状动脉旁路移植手术22例经验总结[J].心肺血管病杂志,2009,28(1):18-20. 被引量:15
  • 10高展,乔树宾.冠状动脉左主干及三支病变的血运重建策略SYNTAX研究解析[J].中华心血管病杂志,2010,38(1):76-79. 被引量:5

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部